CHINA GEWANG BIOTECHNOLOGY, INC. AND SUBSIDIARIES - Consolidated Balance Sheets - USD ($)		May 31, 2016	Nov. 30, 2015
Current Assets:
Cash		$ 16,691,199	$ 8,669,034
Accounts receivable		3,598,376	267,868
Inventory		22,244	156,778
Prepaid expenses		1,547,652	201,369
Total current assets		21,859,471	9,295,049
Property, plant and equipment, net		117,433	65,860
Other assets:
Equity investment		1,874,927
Total Assets		23,851,831	9,360,909
Current Liabilities:
Accounts payable		1,235,947
Taxes payable		406,607	64,153
Accrued expenses and other payables		40,925	175,086
Loans from stockholder		218,069	166,106
Other payable - equity investment		1,000,000
TOTAL CURRENT LIABILITIES		2,901,548	405,345
Stockholders' equity:
Common stock	[1]	75,000	45,500
Additional paid-in capital		16,811,095	6,525,743
Retained earnings		4,016,081	2,270,416
Statutory reserve fund		443,757	281,766
Other comprehensive (loss)		(561,982)	(252,022)
Stockholders' equity before noncontrolling interests		20,783,951	8,871,403
Non-controlling interests		166,332	84,161
Total Stockholders' equity		20,950,283	8,955,564
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY		$ 23,851,831	$ 9,360,909

[1] $0.001 par value, 75,000,000 shares authorized; 75,000,000 and 45,500,000 shares issued and outstanding as of May 31, 2016 and November 30, 2015 respectively